Cyclooxygenase inhibition in patients with coronary artery disease.
作者信息
Frishman William H
出版信息
J Am Coll Cardiol. 2004 Feb 18;43(4):532-3. doi: 10.1016/j.jacc.2003.11.018.
PMID:14975459
Abstract
摘要
相似文献
1
Cyclooxygenase inhibition in patients with coronary artery disease.冠状动脉疾病患者的环氧化酶抑制作用。
J Am Coll Cardiol. 2004 Feb 18;43(4):532-3. doi: 10.1016/j.jacc.2003.11.018.
2
The coxibs, selective inhibitors of cyclooxygenase-2.昔布类药物，环氧化酶-2的选择性抑制剂。
N Engl J Med. 2001 Dec 6;345(23):1709.
3
Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.经皮冠状动脉腔内血管成形术期间阿司匹林对血栓素A(2)生成的最佳抑制作用：选择性环氧化酶-2抑制剂无额外效果
J Am Coll Cardiol. 2004 Feb 18;43(4):526-31. doi: 10.1016/j.jacc.2003.09.041.
4
Efficacy and safety of aspirin in the long-term management of atherothrombosis.阿司匹林在动脉粥样硬化血栓形成长期管理中的疗效与安全性。
Haematologica. 2002 Jan;87(1):6-8.
5
Cardiovascular events and COX-2 inhibitors.心血管事件与COX-2抑制剂
JAMA. 2001 Dec 12;286(22):2810; author reply 2811-2.
6
Biomedicine. Back to an aspirin a day?生物医学。每天一片阿司匹林又回来了？
Science. 2002 Apr 19;296(5567):474-5. doi: 10.1126/science.1071702.
7
COX-2 inhibitors: no pain, no heart gain?环氧化酶-2抑制剂：无痛，无心脏获益？
Harv Heart Lett. 2001 Dec;12(4):2-4.
8
[Clinical pharmacology of selective inhibitors of cyclooxygenase-2].[环氧化酶-2选择性抑制剂的临床药理学]
Acta Otorhinolaryngol Ital. 2003 Aug;23(4 Suppl 74):13-8, 37-40.
9
Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.环氧化酶-2抑制剂在阿司匹林诱发哮喘患者中的成功应用。
South Med J. 2001 Feb;94(2):256-7.
10
Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?癌症中的环氧化酶抑制作用——一条死胡同还是一种新的治疗现实？
N Engl J Med. 2002 Apr 4;346(14):1085-7. doi: 10.1056/NEJM200204043461412.
Zotero 插件